Skip to main content

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences

Read full article at TechCrunch

Originally published by TechCrunch. Summary and curation by DutyStation.ai.

📰 Related Stories

📰 ai-tech

How AI guardrails are impeding the work of offensive cybersecurity researchers

TechCrunch1h ago
📰 ai-tech

Trump: Ratepayer Protection Pledge Ensures Consumers Protected, Economy Grows, and America Leads AI Race

Breitbart1h ago
📰 ai-tech

Mobileye CEO Amnon Shashua to step aside as company pushes into robotaxis, robotics

TechCrunch3h ago
Gemini Spark rolling out to Google AI Pro users in the US
📰 ai-tech

Gemini Spark rolling out to Google AI Pro users in the US

9to5Google4h ago
📰 ai-tech

AMD takes on Nvidia with its Helios AI rack-scale system

TechCrunch5h ago
Gemini for Home context memory expands to 15 mins, Nest Cam July 2026 update rolling out
📰 ai-tech

Gemini for Home context memory expands to 15 mins, Nest Cam July 2026 update rolling out

9to5Google6h ago
← Back to Military News